Patrick Soon-Shiong & Richard Adcock
2 shared events · Importance 3 · Last updated May 27, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Patrick Soon-Shiong: Patrick Soon-Shiong, ImmunityBio's Executive Chairman and Chief Scientific and Medical Officer, is accused of materially overstating Anktiva's capabilities, leading to the FDA warning and subsequent lawsuits.
Richard Adcock: Richard Adcock is the CEO of ImmunityBio and was the recipient of the FDA's warning letter regarding the misleading promotion of Nogapendekin alfa inbakicept.
Apr 02, 2026 · 132 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Patrick Soon-Shiong and Richard Adcock interact across events, view sentiment trends, and discover connected entities.
Open Dashboard